Hansen E
Anesteziol Reanimatol. 2009 Sep-Oct(5):64-70.
The paper gives information on different clinically important aspects associated with reinfusion of wound and drainage bloods to patients. It considers matters, such as the composition of wound and drainage bloods and its comparison with that of donor blood, as well as that of the cell-saver-washed wound blood; clinical and economic efficiency of the reinfusion of wound and drainage bloods; complications due to the reinfusion of unwashed wound and drainage bloods, as well as a number of other important aspects of the problem. Strong evidence is provided that there are presently no clinical, legal, or economic grounds for the reinfiusion of cell-saver-unwashed wound and drainage bloods in clinical practice. Only cell-saver-washed blood must be reinfiused to a patient.
本文提供了与向患者回输伤口引流血相关的不同临床重要方面的信息。它考虑了诸如伤口引流血的成分及其与供血的比较，以及细胞回收洗涤后的伤口血的成分；伤口引流血回输的临床和经济效益；未洗涤的伤口引流血回输引起的并发症，以及该问题的许多其他重要方面。有力证据表明，目前在临床实践中，没有临床、法律或经济依据回输细胞回收未洗涤的伤口引流血。只能将细胞回收洗涤后的血液回输给患者。
